Anti-CD279重组抗体|科研级 Camrelizumab ( 坎利珠单抗 )-重组抗体试剂-泰克生物-酵母展示服务专家

Anti-CD279重组抗体|科研级 Camrelizumab ( 坎利珠单抗 )

详细相关信息靶点背景信息实验方案&FAQ 相关产品推荐服务

询价与订购

姓名*
电话号码*
电子邮件*
产品名称*
描述*

Anti-CD279重组抗体|科研级 Camrelizumab ( 坎利珠单抗 )

说明书联系我们

< >

详细相关信息

靶点背景信息

实验方案&FAQ

Catalog Number

TKYR1436

Alias

科研级 Camrelizumab ( 坎利珠单抗 ), Anti-CD279 Recombinant Antibody, Research Grade Camrelizumab

Molecular Name

Camrelizumab

Size

1mg, 5mg

CAS Number

1798286-48-2

Isotype

IgG4 Kappa

Clonality

Monoclonal

Concentration

1mg/ml

Applications

ELISA, IHC, IF, IP, Flow Cyt, Block

Source

CHO Cells

Purity

≥95% as determined by SDS-PAGE

Buffer

Supplied in PBS, PH7.5

Target

PDCD1/PD-1/CD279[Homo sapiens]

Background

Camrelizumab (SHR-1210) (INN) is an anti-PD-1 immune checkpoint inhibitionitor that is being investigated for hepatocellular carcinoma and Hodgkin lymphoma. This drug is being developed by Jiangsu HengRui Medicine Co., Ltd. As of 2019, camrelizumab is undergoing Phase II/III trials.

Storage

该产品可在 2°C-8°C 下保存一个月，活性不会明显降低。在 -20°C 至 -80°C 下保存，可稳定保存十二个月。避免反复冻融,用冰袋运输。

NOTE

仅科研使用

靶点背景信息

实验方案&FAQ